Astrana Health, Inc. - 8-K Filing
Astrana Health reported Q1 2026 revenue of $965.1 million, up 56% YoY, with adjusted EBITDA of $66.3 million (up 82% YoY) and free cash flow of $64.1 million (up 372% YoY). The company also announced a conference call on May 7, 2026, to discuss results and provided 2026 guidance for total revenue of $3.8–4.1 billion and adjusted EBITDA of $250–280 million. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure)
Tickers: $ASTH